Arno J. Mundt, MD

Arno J. Mundt, MD

Professor and Chair Gynecologic Cancers
Prostate Cancer
Pediatric Cancers
Intensity Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT) Stereotactic Radiosurgery
Stereotactic Radiosurgery (Brain)
Stereotactic Radiosurgery (Body)

Contact Information

Department of Radiation Medicine and Applied Sciences
Moores Cancer Center
3855 Health Sciences Drive, #0843
La Jolla, CA 92093-0843

UCSD Radiation Oncology North County – Encinitas
Multi-Specialty Clinic
1200 Garden View Road, Suite 210
Encinitas, CA 92024


A native of Honolulu, Hawaii, Dr. Mundt graduated from Stanford University with a degree in Philosophy and went on to Medical School at the University of Michigan in Ann Arbor. Following Medical School, he completed an Internship in Internal Medicine and a Residency in Physical Medicine and Rehabilitation at George Washington University in Washington DC. During his PM&R training, Dr. Mundt developed an interest in Oncology and decided to enter the field of Radiation Oncology.

Following a residency in Radiation Oncology in the Department of Radiation and Cellular Oncology at the University of Chicago, Dr. Mundt joined the faculty at that institution initially as an Assistant Professor and was later promoted to Associate Professor. He also served as the Director of the Residency Training Program and Medical Director of the University of Illinois at Chicago. In March 2006, Dr. Mundt was recruited to be Professor and Chair of the Department of Radiation Oncology at the University of California, San Diego (UCSD).

Dr. Mundt is an internationally recognized radiation oncologist. He has published over 100 journal articles, book chapters and reviews predominantly focusing on the use of novel radiotherapy approaches including intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT) and stereotactic radiosurgery. He has edited 3 oncology textbooks, including two devoted to novel radiation technologies: IMRT: A Clinical Perspective and IGRT: A Clinical Perspective. The latter includes contributors from over 77 institutions in 18 countries. He has been an invited speaker at over 150 seminars, symposia and workshops in the United States and abroad, including in Australia, Brazil, Canada, Chile, China, England, Japan and Taiwan. He has been a visiting professor at numerous prestigious Universities, including the Mayo Clinic, the University of Michigan, Washington University, and Emory. He is a guest reviewer for 8 cancer journals and serves on multiple Advisory and Editorial Boards. Named Top Doctor for Cancer as well as a Top Doctor by the Chicago Magazine, he has recently been named a Top Doctor by the San Diego Magazine.

Outside the hospital, Dr. Mundt is an avid classical pianist and racquetball player. He enjoys travel and has a considerable interest in foreign languages, having studied 8 languages (his best are French, German and Italian). A life-long tennis enthusiast, Dr. Mundt was a frequent tennis partner of Barack “Barry” Obama while growing up in Hawaii.

Original Peer Reviewed Publications

  1. Mundt, A.J., Sibley, G., Williams, S., Rubin, S., Halpern, H., Heimann, R.,Weichselbaum, R. Patterns of Failure and Outcome of Complete Responders Following
    High-Dose Chemotherapy and Autologous Bone Marrow Transplantation for Metastatic
    Breast Cancer. Int J Radiat Oncol Biol Phys 30:151-160, 1994. See Editorial
    Marks LB, Prosnitz LR. Is there a role for radiotherapy in the "curative" management of patients with metastatic cancer? Int J Radiat Oncol Biol Phys 1994;30:243-4
  2. Mundt, A.J., Awan, A.J., Sibley, G., Simon, M., Rubin, S., Samuels, B., Wong, W., Beckett, M., Vijayakumar, S., Weichselbaum, R. Conservative Surgery and Adjuvant Radiation Therapy in the Management of Adult Soft Tissue Sarcoma of the Extremities: Clinical and Radiobiologic Results. Int J Radiat Oncol Biol Phys 32:977-985, 1995. See Editorial
    Suit H. Sarcoma of soft tissues: radiation sensitivity, treatment field margins, pathological
    margins, and dose. Int J Radiat Oncol Biol Phys 1995;32:1545-6
  3. Mundt, A.J., Sibley, G., Williams, S. Hallahan, D., Weichselbaum, R. Patterns of Failure and Outcome Following High-Dose Chemotherapy and Bone Marrow Transplantation With Involved Field Radiotherapy for Relapsed/Refractory Hodgkin's Disease. Int. J. Radiat. Oncol.Biol Phys. 33:261-270,1995. See Editorial
    Yahalom J. Integrating radiotherapy into bone marrow transplantation programs for Hodgkin's disease. Int J Radiat Oncol Biol Phys 1995;33:525-8
  4. Mundt, A.J., Sibley, G., Williams, S., Rubin, S., Halpern, H., Heimann, R.,
    Weichselbaum, R. Patterns of Failure and Outcome of Complete Responders Following
    High-Dose Chemotherapy and Autologous Bone Marrow Transplantation for Metastatic
    Breast Cancer. Int J Radiat Oncol Biol Phys 30:151-160, 1994.
  5. Li C, Crawford S, Mundt AJ, Vijayakumar S. Computer-aided treatment design of a distal upper extremity soft tissue tumor with electron beam radiotherapy. Med Dosim 1993;18:143-8.
  6. Mundt, A.J., Sibley, G., Williams, S., Rubin, S., Halpern, H., Heimann, R., Weichselbaum, R. Patterns of Failure and Outcome of Complete Responders Following High-Dose Chemotherapy and Autologous Bone Marrow Transplantation for Metastatic Breast Cancer. Int J Radiat Oncol Biol Phys 30:151-160, 1994.
    See Editorial
    Marks LB, Prosnitz LR. Is there a role for radiotherapy in the “curative” management of patients with metastic cancer? Int J Radiat Oncol Biol Phys 1994;30:243-4.
  7. Mundt, A.J., Awan, A.J., Sibley, G., Simon, M., Rubin, S., Samuels, B., Wong, W., Beckett, M., Vijayakumar, S., Weichselbaum, R. Conservative Surgery and Adjuvant Radiation Therapy in the Management of Adult Soft Tissue Sarcoma of the Extremities: Clinical and Radiobiologic Results. Int J Radiat Oncol Biol Phys 32:977-985, 1995. See Editorial
    Suit H. Sarcoma of soft tissues: radiation sensitivity, treatment field margins, pathological margins, and dose. Int J Radiat Oncol Biol Phys 1995;32:1545-6.
  8. Mundt, A.J., Sibley, G., Williams, S. Hallahan, D., Weichselbaum, R. Patterns of Failure and Outcome Following High-Dose Chemotherapy and Bone Marrow Transplantation With Involved Field Radiotherapy for Relapsed/Refractory Hodgkin's Disease.
    Int J Radiat Oncol Biol Phys 33:261-270,1995.
    See Editorial
    Yahalom J. Integrating radiotherapy into bone marrow transplantation programs for Hodgkin's disease. Int J Radiat Oncol Biol Phys 1995;33:525-8.
  9. Sibley, G., Mundt, AJ, Goldman, S., Nachman, J., Johnson, L., Weichselbaum, R., Hallahan, D. The Patterns of Failure Following Total Body Irradiation and Bone Marrow Transplantation +/- Local Radiation Therapy Boost for Advanced Neuroblastoma Int J Radiat Oncol Biol Phys 32:1127-1135, 1995.
  10. Roeske, J., Kuchnir, F., Mundt, AJ, Haraf, D. Photon and Electron Field Matching in the Treatment of Tumors of the Paranasal Sinuses: A Case Report. Med Dosim. 21:31-36, 1996.
  11. Sibley, G., Mundt, A.J., Shapiro C., Jacobs R., Chen G., Weichselbaum R., Vijayakumar, S. Treatment of Stage III Non-Small Cell Lung Cancer Using High Dose Conformal Radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 33:1001-1007, 1995.
  12. Chen L., Mundt, A.J., Powers C., Halpern H., Weichselbaum R. Significance of family history in breast cancer treated with breast conservation therapy. Breast J. 2:238-245, 1996
  13. Jaffey P., Mundt, A.J., Baunoch D., Armstron D., Hamilton W., Zagaya V., Grossman R., Wollman R. The clinical significance of extracellular matrix in gangliogliomas. J Neuropath Exp Neurol 55:1246-1252, 1996.
  14. Gibbs P., Peabody T., Mundt, A.J., Montag A., Simon M. Oncologic Outcomes of Subcutaneous Sarcomas of the Extremities. J Bone J Surg 79A:888-897, 1997.
  15. Roeske J., Mundt, A.J., Halpern H., Sweeney P., Sutton H., Powers C., Rotmensch J., Waggoner S., Fleming G., Weichselbaum R. Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis. Int. J. Radiat. Oncol. Biol. Phys. 37:351-358, 1997.
  16. Mundt, A.J., Williams, S.F., Hallahan, D.E. Patterns of failure and outcome of patients with aggressive non-Hodgkin's lymphoma undergoing high dose chemotherapy and stem cell rescue. Int. J. Radiat. Oncol. Biol. Phys. 39:617-626, 1997.
  17. Kowalczuk A., Macdonald R.L., Amidei, C., Dohrmann, G., Erickson ,R.K., Hekmatpanah, J., Krauss, S., Krishnasamy, S., Masters, G., Mullan, S.F., Mundt, A.J., Sweeney, P., Vokes, E.E., Weir, B.K.A., Wollman, R.L. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery 41:1028-1038, 1997
  18. Mitchell, P.A., Rotmensch, J., Waggoner, S., Mundt, A.J. Radiation therapy in elderly patients with cervical carcinoma. Gynecol Oncol 71:291-298, 1998.
  19. Mundt, A.J., Connell, P.P., Campbell, T., Hwang, J., Rotmensch, J., Waggoner, S. Race and clinical outcome in patients with cervical carcinoma undergoing radiation therapy. Gynecol Oncol 71:151-158. 1998. See Editorial
    Parham G, Hicks M. Race as a Factor in the Outcome of Patients with Cervical Cancer: Lift the Veil to Find the Wounded Spirit. Gynecol Oncol 1998;71:149-150.
  20. Mundt, A.J., Rotmensch, J., Waggoner, S., Quiet, C., Fleming, G. Phase I trial of concomitant chemoradiotherapy for cervical cancer and other advanced pelvic malignancies. Gynecol Oncol 72:45-50, 1999.
  21. Mundt, A.J., Waggoner, S., Rotmensch, J., Herbst, A.J. Preoperative intracavitary brachytherapy in early stage cervical carcinoma, Am J Clin Oncol 22:737-7, 1999.
  22. Weiss, M., Connell, P.P., Rotmensch, J., Waggoner, S., Mundt A.J. External pelvic radiation therapy in stage IC endometrial carcinoma, Obstet Gynecol 93:599-602, 1999.
  23. Czyzewski, E.A.D., Goldman, S., Mundt, A.J., Nachman, J., Rubin, C., Hallahan, D.E. Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue: a feasibility study. Int J Radiat Oncol Biol Phys 44:569-577, 1999.
  24. Calvin, D., Connell, P.P., Rotmensch, J., Waggoner, S., Mundt, A.J. Surgery and adjuvant radiation therapy in stage II endometrial carcinoma. Am J Clin Oncol 22:238-243, 1999.
  25. Connell, P.P., Mansur, D.B., Macdonald, L., Nicholas, K.E., Mundt, A.J. Tumor size predicts control in benign meningiomas. Neurosurgery 44:1194-1200, 1999.
  26. Connell, P.P., Rotmensch, J., Waggoner, S., Mundt, A.J. Significance of adnexal involvement in endometrial carcinoma. Gynecol Oncol 74:74-79, 1999.
  27. Connell, P,P., Waggoner, S., Rotmensch, J., Mundt, A.J. Race and clinical outcome in endometrial carcinoma. Obstet Gynecol 94:713-20, 1999.
  28. Mundt, A.J., Connell, P.P., Mansur, D.B. What is the optimal treatment volume in Hodgkin's disease patients undergoing high dose chemotherapy, stem cell rescue and adjuvant radiation therapy? Radiat Oncol Invest 7:353-359, 1999
  29. Mansur, D.B., Hekmatpanah, J., Wollman, R., Macdonald, L., Nicholas, K., Beckman, E., Mundt, A.J. Low grade gliomas treated with adjuvant radiation therapy in the modem imaging era. Am J Clin Oncol 23:222-6, 2000.
  30. Wollschlaeger, K. Connell, P.P., Waggoner, S., Rotmensch, J., Mundt, A.J. Acute problems during low-dose-rate intracavitary brachytherapy for cervical carcinoma, Gynecol Oncol 76:67-72, 2000.
  31. Tran, B.N., Connell, P.P., Waggoner, S., Rotmensch, J., Mundt, A.J. Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. Am J Clin Oncol 23:476-80, 2000.
  32. Mundt, A.J., Connell, P.P. Do conventional pathologic features lose their prognostic significance following postoperative radiation therapy in pathologic stage 1-H endometrial carcinoma? Int J Cancer 90:224-30, 2000.
  33. Castro, I,N., Connell, P.P., Waggoner, S., Rotmensch, J., Mundt, A.J. Synchronous ovarian and endometrial malignancies. Am J Clin Oncol 23:521-5, 2000.
  34. Rotmensch, J., Connell, P.P., Yamada, D., Waggoner, S.E., Mundt, A.J. One versus two intracavitary brachytherapy applications in early stage cervical cancer patients undergoing definitive radiation therapy. Gynecol Oncol 78:32-38, 2000.
  35. Mundt, AJ, Waggoner, S., Yamada, D., Rotmensch, J., Connell, P.P. Age as a prognostic factor for recurrence in patients with endometrial carcinoma. Gynecol Oncol 79:79-85, 2000.
  36. Roeske, JC, Lujan, A, Rotmensch, J, Waggoner, SE, Yamada, D., Mundt, AJ. Intensity modulated whole pelvic radiation therapy in patients with gynecological malignancies. Int J Radiat Oncol Biol Phys 48:1613-21, 2000.
    See Commentary
    Petersen I. Intensity modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Roeske JC et al. Int J Radiat Oncol Biol Phys 2000;48:1613-21. Women's Oncol Rev 2001;1:89-90.
  37. Lapeyre M, Hoffstetter S, Peiffert D, Guerif S, Maire F, Dolivet G, Toussaint B, Mundt AJ, Chassagne JF, Simon C, Bey P. Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins. Int J Radiat Oncol Biol Phys 48:37-42, 2000.
  38. Mundt AJ. Commentary on “Postoperative pelvic radiotherapy improved locoregional control but not survival in stage I endometrial carcinoma” Creutzberg CL, van Putten WLJ, Koper PCM, et al. Lancet 2000;355:1404-1411. Evidence-based Obstet Gynecol 3:46-47, 2001.
  39. Mundt AJ, Rotmensch J, Waggoner, S, Yamada SD, Fleming G. Phase I trial of concomitant vinorelbine, paclitaxel and pelvic radiation therapy for cervical cancer and other advanced pelvic malignancies. Gynecol Oncol 82:333-337, 2001.
  40. Ashman JA, Connell PP, Rotmensch J, Waggoner S, Yamada SD, Mundt AJ. Outcome and management of endometrial carcinoma patients with involvement of the uterine serosa. Gynecol Oncol 82:338-343, 2001.
  41. Mundt AJ, McBride R, Rotmensch J, Waggoner SE, Yamada SD, Connell PP. Pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients following adjuvant chemotherapy alone: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 50:1145-53, 2001.
  42. Mundt AJ, Murphy K, Rotmensch J, Waggoner SE, Yamada SD, Connell PP. Surgery and postoperative radiation therapy in FIGO stage IIIC endometrial carcinoma. Int J Radiat Oncol Biol Phys 50:1154-1160, 2001.
  43. Mundt AJ, Roeske JC, Lujan A, Yamada SD, Waggoner SE, Fleming GF, Rotmensch J. Initial clinical experience using intensity modulated whole pelvic radiation therapy for gynecologic malignancies. Gynecol Oncol 82:456-63, 2001.
  44. Phelan C, Montag A, Rotmensch J, Yamada SD, Waggoner SE, Mundt AJ. Outcome and management of pathologic stage I endometrial cancer patients with involvement of the lower uterine segment. Gynecol Oncol 83:513-517, 2001.
  45. Mundt AJ, Lujan AE, Rotmensch J, Waggoner SE, Yamada SD, Fleming G, Roeske JC. Intensity modulated whole pelvic radiation therapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 52:1330-7, 2002.
    See Commentary
    Wolfson A. Intensity modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Mundt AJ et al. Int J Radiat Oncol Biol Phys 2002;52:1330-7. Women's Oncol Rev 2002;2:345-46.
  46. Mundt AJ, Roeske JC, Lujan AE. Intensity-modulated radiation therapy in gynecologic malignancies. Med Dosim 27:131-136, 2002.
  47. Mundt AJ. Intensity modulated radiation therapy- a revolution in cancer care. Men’s Total Health Digest 2:44, 2002.
  48. Brixey C, Roeske JC, Lujan AE, Mundt AJ. Impact of intensity modulated whole pelvic radiation therapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 54:1388-96, 2002.
  49. Mundt AJ, Roeske JC. Can intensity modulated radiation therapy replace brachytherapy in the treatment of patients with cervical cancer? Point. Brachytherapy 1:192-3, 2002.
    See Counterpoint
    Alektiar K. Can intensity modulated radiation therapy replace brachytherapy in the treatment of patients with cervical cancer? Point. Brachytherapy 1:191-2, 2002.
  50. Murphy K, Rotmensch J, Yamada SD, Mundt AJ. Patterns of failure and outcome of clear cell carcinoma of the uterus: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 55:1272-6, 2003.
  51. Mundt AJ, Mell LK, Roeske JC. Preliminary analysis of chronic gastrointestinal toxicity in patients with gynecologic malignancies treated with intensity modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 56:1354-1360, 2003.
  52. Torres IJ, Mundt AJ, Sweeney PJ, Llanes-Macy MS, Dunaway L, Macdonald RL. A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors. Neurology 60:1113-8, 2003.
  53. Mell LK, Roeske JC, Mundt AJ. Survey of intensity modulated radiation therapy use in the United States. Cancer 98:204-11, 2003.
  54. Mell LK, Mundt AJ. Concern with "Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer?" (Letter to the Editor). Gynecol Oncol 2003;90:499.
  55. Lujan AE, Mundt AJ, Yamada SD, Rotmensch J, Roeske JC. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:516-21.
  56. Mehta N, Yamada SD, Rotmensch J, Mundt AJ. Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 2003;57:1004-1009.
  57. Engelhard HH, Stelea A, Mundt AJ. Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment and prognosis. Surg Neurol 2003;60:443-56.
  58. Roeske JC, Bonta D, Lujan AE, Mell LK, Yamada SD, Rotmensch J, Mundt AJ. A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy. Radiother Oncol 2003;69:201-7.
  59. Roeske JC, Lund C, Pelizzari CA, Pan X, Mundt AJ. Reduction of computed tomography metal artifacts due to the Fletcher-Suit applicator in gynecology patients receiving intracavitary brachytherapy. Brachytherapy 2003;2:207-214.
  60. Brockstein B, Mundt AJ, Haraf DJ, Ferguson M, Montag AG. Radiation-induced leiomyosarcoma: does antimetabolite chemotherapy contribute? A report of three cases. Sarcoma 2003;7:167-172.
  61. Mundt AJ, Rotmensch J, Waggoner SE, Yamada SD, Fleming GF. Phase I trial of concomitant vinorelbine, cisplatin and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies. Gynecol Oncol 2004;92:801-5.
  62. Salama JK, Roeske JC, Mehta N, Mundt AJ. Intensity modulated radiotherapy therapy in gynecologic malignancies. Curr Treat Options Oncol 2004;5:97-108.
  63. Citron J, Mundt AJ. Pathologic stage I-II endometrial cancer in the elderly: radiotherapy indications and outcome. Int J Radiat Oncol Biol Phys 2004;59:1432-1438.
  64. Schomas DA, Milano MT, Roeske JC, Mell LK, Mundt AJ. Intensity modulated radiation therapy and the Internet: evaluation of the content and quality of patient-oriented information. Cancer 2004;101:412-20.
    See News Article
    Boggs W. Radiation Therapy Information on the Internet Deemed Poor. Reuters News Health Information. http://www.mercksource.com/pp/us/cns/cns_newsarticleprint Accessed 9/1/04.
  65. Mell LK, Meyer JJ, Tretiakova M, Kramtsov A, Gong C, Yamada SD, Montag AG, Mundt AJ. Prognostic significance of E-cadherin protein expression in pathologic stage I-III endometrial cancer. Clin Cancer Res 2004;10:5546-53.
  66. Mundt AJ, Vijayakumar S, Nemunaitis J, Sandler A, Schwartz H, Hanna N, Peabody T, Senzer N, Chu K, Rasmussen CS, Kessler PD, Rasmussen HS, Warso M, Kufe DW, Das Gupta T, Weichselbaum RR. A Phase I Trial of TNFerade Biologic in Patients with Soft Tissue Sarcoma in the Extremities. Clin Cancer Res 2004;10:5747-53.
  67. Mell LK, Mundt AJ. Radiation therapy in the elderly. Geriatrics Aging 2005;8:50-56
  68. Xia D, Roeske JC, Yu L, Pelizzari CA, Mundt AJ, Pan X. A hybrid approach to reducing computed tomography metal artifacts in intracavitary brachytherapy. Brachytherapy 2005;4:18-23
  69. Haslam JJ, Lujan AE, Mundt AJ, Bonta DV, Roeske JC. Setup errors in patients treated with intensity modulated whole pelvic radiation therapy for gynecological malignancies. Med Dosim 2005;30:36-42.
  70. Schroder M, Mell LK, Hurteau JA, Collins YC, Rotmensch J, Waggoner SE, Yamada SD, Small W, Mundt AJ. Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients. Int J Radiat Oncol Biol Phys 2005;61:1078-86.
  71. Schomas DA, Roeske JC, Macdonald RL, Mehta N, Sweeney PJ, Mundt AJ. Predictors of tumor control in patients treated with linac-based stereotactic radiosurgery for metastatic disease to the brain. Am J Clin Oncol 2005;28:180-7
  72. Malik R, Oh JL, Roeske JC, Mundt AJ. Survey of resident education in intensity modulated radiation therapy. Technol Cancer Res Treat 2005;4:303-10
  73. Agulnik M, Rhee EN, Yao M, Mundt AJ, Feldman LE. Paclitaxel, carboplatin and concomitant radiotherapy for resected patients with high risk head and neck cancer. J Chemother 2005;17:237-41.
  74. Modi BJ, Knab B, Feldman LE, Mundt AJ, Yao M, Pytynia KB, Epstein J. Review of current treatment practices for carcinoma of the head and neck. Expert Opin Pharmacother 2005;6:1143-55
  75. Mundt AJ, Mell LK, Roeske JC. IMRT Utilization. Adv Imaging Oncol Administrators July, 2005.
  76. Mell LK, Mundt AJ. Survey of IMRT use in the United States, 2004. Cancer 2005;104:1296-1303
  77. Montenegro CR, de Castro Neto AJ, Mundt A. Radioterapia de intensidade modulada pelvica. Câncer Hoje. A Oncologia baseada em Evidencias 2005;3:10-11.
  78. Roeske JC, Lujan A, Reba RC, Penney BC, Yamada SD, Mundt AJ. Incorporation of SPECT bone marrow imaging in intensity modulated whole pelvic radiation therapy treatment planning for gynecologic malignancies. Radiother Oncol 2005;77:11-7
  79. Mell LK, Mundt AJ. Radiation Therapy in the Elderly. Cancer J 2005;11:495-505
  80. Silverberg W, Roeske JC, Mehta N, Mundt AJ. Intensity modulated radiation therapy in gynecologic malignancies. Women’s Oncol Review (in press).
  81. Kochanski J, Mundt AJ. Preliminary Analysis of RTOG 9708: Adjuvant Postoperative Radiotherapy Combined with Cisplatin/Paclitaxel Chemotherapy after Surgery for Patients with High-Risk Endometrial Cancer. Greven K, Winter K, Underhill K, et al. Int J Radiat Oncol Biol Phys 2004;59:168-173. Women's Oncol Rev (in press)
  82. Mell LK, Kochanski JD, Roeske JC, Haslam J, Mehta N, Yamada SD, Hurteau J, Collins Y, Lengyel E, Mundt AJ. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys (in press)
  83. Salama JK, Mundt AJ, Roeske JC, Mehta N. Preliminary outcome and toxicity report of extended field intensity modulated radiation therapy for gynecologic malignancies. Int J Radiat Oncol Biol Phys (in press)
  84. Aydogan B, Wang S, Smith B, Mundt AJ, Roeske JC. IMRT as an alternative to intracavitary HDR vaginal brachytherapy in patients with early stage endometrial cancer. Int J Radiat Oncol Biol Phys (in press)
  85. Salama, JK, Aydogan B, Abcarian H, Nelson RL, Cintron JR, Roeske JC, Sutton HG, Smith B, Mundt AJ. Intensity Modulated Radiation Therapy for Anal Cancer. Dis Colon Rectum (under review)
  86. Kochanski JD, Mell LK, Roeske JC, Yamada SD, Collings Y, Hurteau J, Mehta N, Lengyel E, Sutton H, Mundt AJ. Outcome of cervical cancer patients treated with intensity-modulated pelvic radiation therapy. Int J Radiat Oncol Biol Phys (under review)
  87. Kochanski JD, Mell LK, Roeske JC, Mundt AJ. Intensity modulated radiation therapy in gynecologic malignancies: current status and future directions. Clin Adv Hem Oncol (in press)
  88. Knab BR, Roeske JC, Yamada SD, Collings Y, Hurteau J, Mehta N, Lengyel E, Sutton H, Mundt AJ. Outcome of endometrial cancer patients treated with intensity-modulated pelvic radiation therapy. Int J Radiat Oncol Biol Phys (under review)
  89. Aydogan B, Wang S, Smith B, Mundt AJ, Roeske JC. A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients. Int J Radiat Oncol Biol Phys 2006;65:266-273
  90. Aydogan N, Roeske JC, Mundt AJ. In response to Drs. Cameron and Cornes “Brachytherapy vs IMRT for irradiation of the vaginal vault: In regard to Aydogan et al (Int J Radiat Oncol Biol Phys 2006;675:266-273) (Letter to the Editor). Int J Radiat Oncol Biol Phys 2006;66:956-957
  91. Kochanski JD, Mell LK, Roeske JC, Mundt AJ. Intensity modulated radiation therapy in gynecologic malignancies: current status and future directions. Clin Adv Hem Oncol 2006:4:379-386
  92. Salama JK, Mundt AJ, Roeske JC, Mehta N. Preliminary outcome and toxicity report of extended field intensity modulated radiation therapy for gynecologic malignancies. Int J Radiat Oncol Biol Phys 2006;65:1170-6
  93. Sandhu A, Mundt AJ. Radiation Therapy for Older Cancer Patients. Aging Health 2006;2:919-930
  94. Aydogan B, Mundt AJ, Roeske JC. Linac-based intensity modulated total marrow irradiation. Technol Cancer Res Treat 2006;5:513-20
  95. Mell LK, Kochanski JD, Roeske JC, Haslam JJ, Mehta N, Yamada SD, Hurteau JA, Collins YC, Lengyel E, Mundt AJ. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:1356-1365
  96. Mell LK, MalikRK, Komaki R, Movsas B, Swann S, Langer C, Antonadou D, Koukourakis M, Mundt AJ. Effect of amifostine on response rates in advanced non-small cell lung cancer patients treated on randomized controlled trials: a meta-analysis. Int J Radiat Oncol Biol Phys 2007;68:111-8
  97. Yao M, Epstein JB, Modi BJ, Pytnia KB, Mundt AJ, Feldman LE. Current surgical treatment of squamous cell carcinoma of the head and neck. Oral Oncol 2007;43:213-23
  98. Pawlicki T, Mundt AJ. Quality in radiation oncology. Med Phys 2007;34:1529-1534
  99. Salama JK, Mell LK, Schomas DA, Miller RC, Devisetty K, Jani AB, Mundt AJ, Roeske JC, Liaw SL, Chmura SJ. Concurrent chemotherapy and intensity modulated radiation therapy for anal cancer patients: a multicenter experience. J Clin Oncol 2007;25:4581-6
  100. Grushko T, Filiaci V, Mundt AJ, Ridderstrale K, Olopade OI, Fleming G. An exploratory analysis of HER-2 amplification and over-expression in advanced endo-metrial carcinoma: a gynecologic oncology group study. Gynecol Oncol 2008;108:3-9
  101. Small W Jr, Mell LK, Anderson P, Creutzberg C, De Los Santos J, Gaffney D, Jhingran A, Portelance L, Schefter T, Iyer R, Varia M, Winter K, Mundt AJ. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys 2008;71:428-34
  102. Mell LK, Schomas DA, Salama JK, Devisetty K, Aydogan B, Miller RC, Jani AB, Kindler HL, Mundt AJ, Roeske JC, Chmura SJ. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:1431-7
  103. Ryan CW, Montag AG, Hosenpud JR, Samuels B, Hayden JB, Hung AY, Mansoor A, Peabody TD, Mundt AJ, Undevia S. Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas. Cancer 2008;112:2432-9
  104. Sandhu A, Sethi R, Rice R, Wang JZ, Marcus L, Salem C, Downs T, Parsons JK, Millard F, Pawlicki T, Mundt A. Prostate bed localization with image-guided approach using on-board imaging: reporting acute toxicity and implications for radiation therapy planning following prostatectomy. Radiother Oncol 2008;88:20-5
  105. Mell LK, Mundt AJ. Intensity-modulated radiation therapy in gynecologic cancers: growing support, growing acceptance. Cancer J 2008; 14:198-9
  106. Huq M, Fraass BA, Dunscombe PB, Gibbons JP, Ibbott GS, Medin PM, Mundt A, Mutic S, Plata J, Thomadsen BR, Williamson JF, Yorke ED. A method for evaluating quality assurance needs in radiation therapy. Int J Radiat Oncol Biol Phys 2008;71:S170-3
  107. Mell LK, Tiryaki H, Ahn KH, Mundt AJ, Roeske JC, Aydogan B. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys 2008;71:1504-10
  108. Rose BS, Simpson DR, Nath SK, Mundt AJ. Hypofractionated radiotherapy in the elderly: sometimes less is more. Aging Health 2009;5:359-367
  109. Kitchener HC, Trimble EL, Altgassen C, Aghajanian C, Amant F, Birrer M, Blake P, Boyd J, Brady M, Cantu D, Cibuli M, Copeland L, Creasman W, Creutzberg C, Darcy K, Davidson S, DiSaia P, Filiaci G, Fleming G, Gabra H, Gaffney D, Goldman P, Goodfellow P, Green J, Hall G, Hawnaur J, Hogberg T, Holland C, Hoskins W, Linsey J, Jingran A, Kang S, Kehoe S, Kim JW, Konishi I, Kristensen G, Ledermann J, Leslie K, Lively T, Livesey J, Lu K, Marth C, Mathias L, McCluggage G, McConnell D, McMeekin S, Maxwell L, Miller D, Mundt A, Mutter G, Orton J, Oza A, Perren T, Petryshun R, Pignata S, Podratz K, Powell M, Randall M, Reed N, Sagae S, Salvesen H, Sehouli J, Klinikum V, Sherida E, Slomovitz B, Small W, Stuart G, Swart AM, Symonds P, Tay SK, Thigpen JT, Thomas G, Tominson I, Tongaonkar H, Walker J, Wong YF. Endometrial cancer state of the art science meeting. Int J Gynecol Cancer 2009;19:134-140
  110. Sandhu A, Mundt AJ. Radiation therapy for urologic malignancies in the elderly. Urol Oncol 2009;27:643-52
  111. Vanderspek L, Bauman G, Wang JZ, Yartsev S, Menard C, Cho YB, Mundt AJ, Lawson JD, Murphy KT. Dosimetric comparison of intensity-modulated radiosurgery and helical tomotherapy for the treatment of multiple intracranial metastases. Technol Cancer Res Treat 2009;8:361-7
  112. Lawson JD, Sandhu A, Jiang S, Mundt AJ. Emerging role of stereotactic radiotherapy in the treatment of early stage lung cancer. Curr Ca Ther Rev 2009;5:281-287
  113. Simpson DR, Lawson JD, Nath SK, Rose BS, Mundt AJ, Mell LK. Utilization of
    advanced imaging technologies for target delineation in radiation oncology. J Am Coll Radiol 2009;6:876-883
  114. Nath SK, Sandhu AP, Rose BS, Simpson DR, Nobiensky PD, Wang JZ, Millard F, Kane CJ, Parsons JK, Mundt AJ. Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2010 (in press)
  115. Lim K, Small W, Portelance L, Creutzberg C, Jurgenliemk-Schulz IM, Mundt A, Mell LK, Mayr N, Viswanathan A, Jhingran A, Erickson B, De Los Santos J, Gaffney D, Yashar C, Beriwal S, Wolfson A, Taylor A, Bosch W, El Naqa I, Fyles A for the GYN IMRT Consortium. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervical cancer. Int J Radiat Oncol Biol Phys 2010 (in press)
  116. Liang Y, Messer K, Rose BS, Lewis JH, Jiang SB, Yashar C, Mundt AJ, Mell LK. Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional data. Int J Radiat Oncol Biol Phys 2010 (in press)
  117. Rose BS, Aydogan B, Liang Y, Yeginer M, Hasselle MD, Dandekar V, Bafana R, Yashar CM, Mundt AJ, Roeske JR, Mell LK. Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys 2010 (in press)
  118. Nath SK, Lawson JD, Simpson DR, Vanderpek L, Wnag JZ, Alksne JF, Ciacci J, Mundt AJ, Murphy KT. Single-isocenter frameless intensity-modulated stereotactic radiosurgery for simultaneous treatment of multiple brain metastases: clinical experience. Int J Radiat Oncol Biol Phys 2010 (in press)
  119. Wang JZ, Rice R. Mundt A, Sandhu A, Murphy KT. Image-guided stereotactic spine radiosurgery on a conventional linear accelerator. Med Dosim 2010;35:53-62
  120. Nath SK, Lawson JD, Wang JZ, Simpson DR, Newman CB, Alksne JF, Mundt AJ, Murphy KT. Optically-guided frameless linac-based radiosurgery in brain metastases: clinical experience. J Neurooncol 2010;97:67-72
  121. Lawson JD, Wang JZ, Nath SK, Rice R, Pawlicki T, Mundt AJ, Murphy KT. Intracranial application of IMRT based radiosurgery to treat multiple or large irregular lesions and verification of infra-red frameless localization system. J Neurooncol 2010l97:59-66.

 

Other Publications

  1. Mundt AJ, Roeske JC, Lujan A. “The University Of Chicago Explores the Role of IMRT in Gynecologic Malignancies.” IMRT Insider. Varian Associates. December 2000
  2. Mundt AJ, Roeske JC, Johnson LS. “Intensity-Modulated Radiation Therapy:
    Revolution in the Treatment of Cancer.” University of Chicago Clinical Comment. Fall, 2000
  3. Mundt AJ, Johnson S. Clinical outcome studies in IMRT: a literature review. Varian Centerline Magazine. Fall, 2000
  4. Mundt AJ, Mell LK, Roeske JC. IMRT Utilization. Advance for Imaging and Oncology Administrators. 2005;15(7):51.
  5. Mundt AJ, Pawlicki T, Murphy KT, Goldman MS. “IGRT at an NCI-Designated Comprehensive Cancer Center”. Oncology Issues, May/June, 2007
  6. Yashar CM, Mundt AJ. “Medically SAVI”. Advance for Imaging and Oncology Administrators, Volume 17, Issue 8, page 62, 2007
  7. Lawson JD, Mundt AJ, Murphy KT. “New Tactics: Optically-Guided Frameless Stereotactic Radiosurgery”. Enterprise Imaging & Therapeutic Radiology Management, May 2008, pp 68-70.
 

UpToDate Publications

  1. Chen LM, Mundt AJ, Berek JS. Staging and treatment of endometrial cancer. I. http://www.uptodate.com
  2. Chen LM, Mundt AJ, Berek JS. Staging and treatment of endometrial cancer. II. http://www.uptodate.com
  3. Chen LM, Mundt AJ, Berek JS. Staging and treatment of endometrial cancer. III. http://www.uptodate.com
  4. Goff B, Mundt AJ. Uterine papillary serous and clear cell cancer. http://www.uptodate.com
  5. Memarzadeh S, Mundt AJ, Berek JS. Uterine sarcoma. I. http://www.uptodate.com
  6. Memarzadeh S, Mundt AJ, Berek JS. Uterine sarcoma. II. http://www.uptodate.com
  7. Schwartz P, Mundt AJ. Uterine papillary serous and clear cell cancer. I. http://www.uptodate.com
  8. Schwartz P, Mundt AJ. Uterine papillary serous and clear cell cancer. II. http://www.uptodate.com
  9. Plaxe SC, Mundt AJ. Locally recurrent and advanced endometrial cancer. http://www.uptodate.com
 

On-Line Atlas

  1. Small W, Mundt AJ. Gynecologic Pelvic (IMRT) Atlas. http://www.rtog.org/CoreLab/ContouringAtlases/GYN.aspx

Media Stories/Interviews

  1. “Trilogy Linear Accelerator Destroys Cancer Tumors” Channel 8 San Diego CA News Feature. April 11, 2006.
  2. “UCSD Working to Develop Proton Therapy Cancer Center” Channel 10News.com News Feature. September 12, 2007. http://www.10news.com/health/14100121/detail.html
  3. “UC San Diego Developing $125 Million Cancer Treatment Center” North County Times News Feature. September 13, 2007. http://www.nctimes.com/
  4. “UCSD Plans to Build $125M Proton particle Therapy, Research Center”, San Diego Business Journal, September 24, 2007 http://www.sdbj.com/
  5. “Proton Therapy Holds Big Promises for UCSD Medical Center” The Guardian. September 25, 2007. 
  6. “Image Guided Radiation Therapy”. The Group Room Weekly Call-In Cancer Talk Radio Show, Vital Options International, October 2007. www.vitaloptions.org
  7. “IG-IMRT: Treating Cancers Like Never Before”, Health Imaging & IT Magazine, November 2007. http://www.healthimaging.com/
  8. “Software Helps Target Radiation Treatment for Cancer”, ComputerWorld Magazine, December 3, 2007 http://computerworld.com
  9. “UCSD Radiation Oncology Services Come to North County”, San Diego Daily Transcript, March 2008 http://www.sddt.com/
  10. “Advances in Radiation Therapy for Prostate Cancer”. Ask Dr. Barken San Diego Radio Call-In Program Interview, Prostate Cancer Research and Education Foundation http://www.pcref.org/ , September 2008.
  11. “A Different Kind of Radiation Oncology Department at UCSD”, Varian Medical Systems Centerline Magazine, September 2008
  12. “UCSD Radiation Oncology South Bay”, KUSI-TV, San Diego, CA, November 2009
 

Book Chapters

  1. Drinkard, L.C., Ferguson, M.K., Mundt, AJ, Vokes, E.E. Therapy of Esophageal Cancer. In: Aisner, J., Arriagada, R., Green, M.R., Martini, N., Perry, M.C. (eds). Comprehensive Textbook of Thoracic Oncology. Williams & Wilkins, Baltimore, 1996.
  2. Mundt, AJ, Weichselbaum, R.R. Radiation Therapy in Soft Tissue Tumors. In: Das Gupta T (ed). Soft Tissue Tumors. Williams & Wilkins, Baltimore, 1996.
  3. Mundt, AJ Principles of Radiation Therapy. In: Golomb H, Vokes EE (eds). 1st Edition. Oncologic Therapeutics. Springer-Verlag, Heidelberg, 1998.
  4. Mundt, AJ, Roeske, JC, Weichselbaum, R.R. Principles of Radiation Oncology. In: Holland J, Frei E, Weichselbaum RR (eds). Cancer Medicine. B.C. Decker, Toronto, 1999.
  5. Mundt, AJ Radiation Therapy and the Elderly. In: Hunter CP, Johnson KA, Muss HB (eds). Cancer in the Elderly. Marcel Dekker, Inc., New York, 2000.
  6. Mundt, AJ, Roeske, JC. Principles of Radiation Therapy. In: Golomb H, Vokes EE (eds). Oncologic Therapeutics. 2nd Edition. Springer-Verlag, Heidelberg, 2001.
  7. Mundt AJ, Roeske JC, Chung T, Weichselbaum RR. Principles of Radiation Oncology. In: Holland J, Frei E, Weichselbaum RR (eds). Cancer Medicine. B.C. Decker, Toronto, 2002.
  8. Mundt AJ, Artioli G, Fleming GF. Treatment of Recurrent Endometrial Cancer: Chemotherapy, Hormonal therapy, and Radiation Therapy. In: Gershenson, Gore, McGuire, Quinn, Thomas (eds). Gynecologic Cancer: Controversies in Management. Elsevier Science (USA), Philadephia, 2002.
  9. Rowinsky E, Mundt AJ. 21st Century Innovative Therapies. In: Hoskins WJ, Perez CA, Young RC (eds). Principles and Practice of Gynecologic Oncology. J.B. Lippincott, Philadelphia, 2004.
  10. Burke T, Muggia F, Mundt AJ. Uterine Cancer. In: Devita V, Hellman S, Rosenberg (eds). Principles and Practice of Oncology. Williams and Wilkins, Baltimore, 2005.
  11. Fleming GF, Montag AC, Mundt AJ, Yamada SD. Uterine Malignancies. In: Chang AE, Ganz PA, Hayes DF et al. (Editors). Oncology: An Evidence-Based Approach. Blackwell Publishing Ltd, Oxford, 2005.
  12. Mundt AJ, Wyman B, Chotipradit C, Bruch P, Roeske JC. The IMRT Process. In: Mundt AJ, Roeske JC (eds). Intensity Modulated Radiation Therapy: A Clinical Perspective. B.C. Decker, Toronto, 2005.
  13. Mell LK, Mehta N, Roeske JC, Mundt AJ. Gynecologic Malignancies. In: Mundt AJ, Roeske JC (eds). Intensity Modulated Radiation Therapy: A Clinical Perspective. B.C. Decker, Toronto, 2005.
  14. Kao J, Mundt AJ. Metastatic and Recurrent Disease. In: Mundt AJ, Roeske JC (eds). Intensity Modulated Radiation Therapy: A Clinical Perspective. B.C. Decker, Toronto, 2005.
  15. Roeske JC, Mundt AJ. Bone Marrow Sparing Approaches. In: Mundt AJ, Roeske JC (eds). Intensity Modulated Radiation Therapy: A Clinical Perspective. B.C. Decker, Toronto, 2005.
  16. Mundt AJ, Roeske JC, Chung T, Weichselbaum RR. Principles of Radiation Oncology. In: Holland J, Frei E, Weichselbaum RR (eds). Cancer Medicine. B.C. Decker, Toronto, 2005.Mell LK, Mundt AJ. Radiation Therapy in the Elderly. In: Hunter CP, Johnson KA, Muss HB (eds). Cancer in the Elderly. Marcel Dekker, Inc., New York, 2006
  17. Mell LK, Jiang SB, Pawlicki T, Mundt AJ. Image-Guided Radiation Therapy. In: Principles and Practice of Radiation Oncology. Halperin E, Perez C, Brady L (editors). Lippincott Williams & Wilkins, Baltimore, 2008
  18. Rowinsky E, Mundt AJ. 21st Century Innovative Therapies. In: Hoskins WJ, Perez CA, Young RC (eds). Principles and Practice of Gynecologic Oncology. J.B. Lippincott, Philadelphia, 2008
  19. Mundt AJ. IMRT and Brachytherapy in Cervical Cancer: Friends or Foes? In: Mould RF (editor). Proceedings of the 12th International Conference on Optimal Use of Advanced Radiotherapy in Multimodality Oncology. Nucletron BV, Veenendaal, Netherlands, 2008
  20. Jiang SB, Romejin E, Men C, Tyagi N, Lewis J, Tang L, Choi DJ, Majumdar A, Pawlicki T, Yashar C, Mundt AJ. Towards on –line adaptive radiotherapy for cervical cancer. In: Censor Y, Jiang M, Louis A (eds). Mathematical methods in biomedical imaging and intensity-modulated radiation therapy (IMRT). Edizioni Della Normale, Pisa, Italy, 2008.
  21. Mell LK, Haslam J, Roeske JC, Mundt AJ. Gynecologic Malignancies. In: Image-Guided and Adaptive Radiation Therapy. Timmerman R, Xing L (editors). Lippincott Williams & Wilkins, Philadelphia, 2009.
  22. Ramirez P, Muggia F, Mundt AJ. Uterine Cancer. In: Devita V, Hellman S, Rosenberg (eds). Principles and Practice of Oncology. Williams and Wilkins, Baltimore, 2010
  23. Mundt AJ, Roeske JC. Overview. In: Image-Guided Radiation Therapy: A Clinical Perspective. Mundt AJ, Roeske JC (editors). People Press, Beijing, 2010
  24. Mell LK, Roeske JC, Mundt AJ. Gynecologic Tumors. In: Image-Guided Radiation Therapy: A Clinical Perspective. Mundt AJ, Roeske JC (editors). People Press, Beijing, 2010
  25. Simpson DR, Nath SK, Rose BS, Mell LK, Lawson JD, Mundt AJ. Adaptive Image-Guided Radiation Therapy: A Physician’s Perspective. In: Image-Guided Radiation Therapy: A Clinical Perspective. Mundt AJ, Roeske JC (editors). People Press, Beijing, 2010
 

Books

  1. Cancer Medicine Review. Stone, R.M., Essner, R., Mundt, A.J. (eds). Williams & Wilkins, Baltimore, 1997.
  2. Intensity Modulated Radiation Therapy: A Clinical Perspective. Mundt AJ, Roeske JC (eds). B.C. Decker, Toronto, 2005
  3. Image-Guided Radiation Therapy: A Clinical Perspective. Mundt AJ, Roeske JC (editors). Peoples Press, Beijing 2010 (in press)
  4. Quality and Safety in Radiotherapy. Pawlicki T, Dunscombe P, Mundt AJ, Scalliet P (editors). (in press)
 

Invited Lectures

  1. “Rehabiliation Issues in Radiation Oncology” Schwab Rehabilitation Institute, Chicago IL, August 1996
  2. “Radiation Therapy vs Surgery in Early Stage Cervical Cancer” University of Chicago, Department of Obstetrics and Gynecology, Grand Rounds, November 1997
  3. “Radiation Therapy in Ovarian Cancer: An Un-American Approach” University of Chicago, Department of Obstetrics and Gynecology, Grand Rounds, August 1998
  4. “Clinical Issues in Intensity Modulated Radiation Therapy” Second Hong Kong International Symposium on Recent Advances in Radiotherapy: IMRT” Hong Kong, People’s Republic of China, "
    Feb 2001
  5. "Physician Perspective on IMRT” Varian Associates Symposia on Intensity Modulated Radiation Therapy: Phoenix, Arizona, May 2000.
  6. “Physician Perspective on IMRT” Varian Associates Symposia on Intensity Modulated Radiation Therapy: Washington DC, October 2000.
  7. “Physician Perspective on IMRT” Varian Associates Symposia on Intensity Modulated Radiation Therapy: Long Beach, California, September 2000.
  8. “Physician Perspective on IMRT” Varian Associates Symposia on Intensity Modulated Radiation Therapy: San Francisco, California, November, 2000
  9. “Clinical Issues in Intensity Modulated Radiation Therapy” Varian Associated Symposia on Intensity Modulated Radiation Therapy, American Society for Therapeutic Radiology and Oncology, Boston, Massachusetts, November 2000.
  10. “Physician Perspective on IMRT” Varian Associates Symposia on Intensity Modulated Radiation Therapy: Taipei, Republic of China, February 2001.
  11. “Clinical Experience with Intensity Modulated Whole Pelvic Radiation Therapy in Gynecologic Malignancies” Varian European Users Meeting 2001. Sardinia, Italy, June 2001.
  12. “Intensity Modulated Radiation Therapy: A Revolution in the Treatment of Cancer” LaGrange Memorial Hospital (Medical Grand Rounds), LaGrange Park, Illinois, July, 2001
  13. “Intensity Modulated Radiation Therapy in Gynecologic Malignancies” Stanford University IMRT Course, Palo Alto, CA, August, 2001
  14. “Quality Assurance Issues in Intensity Modulated Radiation Therapy” Japanese Association for Therapeutic Radiology and Oncology, Osaka, Japan, November, 2001
  15. “A Review of Clinical Studies in Intensity Modulated Radiation Therapy” Japanese Association for Therapeutic Radiology and Oncology, Osaka, Japan, November, 2001
  16. “Clinical Experience with Intensity Modulated Radiation Therapy in Gynecologic Malignancies” Japanese Association for Therapeutic Radiology and Oncology, Osaka, Japan, November, 2001
  17. “Intensity modulated radiation therapy: A physician’s perspective”. Varian Associates Symposia on Intensity Modulated Radiation Therapy: University of Pittsburgh, Pittsburgh, PA, December 2001.
  18. “A Review of Clinical Studies in Intensity Modulated Radiation Therapy”, Varian Associates Symposia on Intensity Modulated Radiation Therapy: Kyoto, Japan, March 2002
  19. “Intensity modulated radiation therapy: A physician’s perspective”. Varian Associates Symposia on Intensity Modulated Radiation Therapy: Denver, CO, March 2002.
  20. “A Review of Clinical Studies in Intensity Modulated Radiation Therapy”, Varian Associates Symposia on Intensity Modulated Radiation Therapy: St Louis, MI, April 2002
  21. “Clinical Outcome Studies in Intensity Modulated Radiation Therapy”, Varian Associates Symposia on Intensity Modulated Radiation Therapy: San Jose, CA, June 2002
  22. “Intensity modulated radiation therapy: A physician’s perspective”. Varian Associates Symposia on Intensity Modulated Radiation Therapy: Cleveland, OH, June 2002.
  23. “Clinical Outcome Studies in Intensity Modulated Radiation Therapy”, Varian Associates Symposia on Intensity Modulated Radiation Therapy: Hershey, PA, June 2002
  24. Intensity modulated radiation therapy: A physician’s perspective”. Varian Associates Symposia on Intensity Modulated Radiation Therapy: Milwaukee, WI, July, 2002.
  25. “Intensity Modulated Radiation Therapy in Gynecologic Malignancies” Stanford University IMRT Course, Palo Alto, CA, August, 2002
  26. “Clinical Outcome Studies in Intensity Modulated Radiation Therapy”, Varian Associates Symposia on Intensity Modulated Radiation Therapy: Minneapolis, MN, August, 2002
  27. Gynecologic IMRT: Present Status and Future Directions”, Varian Associates ASTRO Symposia on Intensity Modulated Radiation Therapy: New Orleans, LA, October, 2002
  28. “Current Status of IMRT”, Varian Industry Workshop, Canadian Association of Radiation Oncology, Toronto, Canada, October, 2002
  29. “Clinical Outcome Studies in Intensity Modulated Radiation Therapy” Japanese Association for Therapeutic Radiology and Oncology, Tokyo, Japan, November, 2002
  30. “Intensity modulated radiation therapy: the physician’s perspective” Japanese Association for Therapeutic Radiology and Oncology, Tokyo, Japan, November, 2002
  31. “IMRT: current status and future directions” Japanese Association for Therapeutic Radiology and Oncology, Tokyo, Japan, November, 2002
  32. “IMRT and Emerging Technologies” Varian IMRT Symposium, Portland, OR, January 2003.
  33. “IMRT- A physician’s perspective” ASTRO Practicum “Implementing IMRT in Clinical Practice”, San Diego, CA, February 2003
  34. “IMRT in CNS Malignancies” Indiana University Radiation Oncology Seminar, Haleiwa, Hawaii, February 2003
  35. “IMRT in Gynecologic Malignancies” Indiana University Radiation Oncology Seminar, Haleiwa, Hawaii, February 2003
  36. “Clinical Outcome Studies in IMRT” American College of Radiation Oncology, Phoenix, AZ, February, 2003
  37. “Role of IMRT in Gynecologic Malignancies” Stanford University IMRT Course, Palo Alto, CA, April, 2003
  38. “Radiation Therapy and Prostate Cancer” Urology Grand Rounds, University of Illinois at Chicago, IL, May 2003
  39. “Clinical Outcome Studies in IMRT” Varian IMRT Symposium, Huntington Beach, CA, May 2003.
  40. “Role of IMRT in Gynecologic Malignancies” Radiation Therapy Oncology Group, Montreal, Canada, June 2003
  41. “Radiation Oncology and Cancer” University of Illinois Cancer Center, Employee Lecture Series, Chicago IL, July 2003
  42. “IMRT is the Future of Radiation Therapy Planning in Gynecologic Malignancies. Yes” Controversies in Cervical and Endometrial Cancer, Gynecologic Oncology Group Seminar (Debate), Reno NV, July 2003
  43. “Clinical Outcome Studies in IMRT: An Update” 12th International Congress of Radiation Research. Brisbane, Australia, August 2003.
  44. “Clinical Studies in IMRT” World Congress of Medical Physics and Biomedical Engineering, Sydney, Australia, August 2003.
  45. “Target Delineation and Dose Specification in Gynecologic IMRT” (Refresher Course), American Society for Therapeutic Radiology and Oncology, Salt Lake City, UT, October 2003.
  46. “Clinical Outcome Studies in IMRT” Varian IMRT Symposium, Indianapolis, IN, October 2003.
  47. “Advances in Radiation Oncology”, Methodist Hospital Grand Rounds, Merrillville, IN, October 2003.
  48. “Clinical Outcome Studies in IMRT”, Varian IMRT Symposia, Santiago, Chile, October 2003.
  49. “Radiation Therapy in the Elderly” Third Annual Geriatric Oncology Conference, “Maximizing Cancer Care in the Older Patient” University of Chicago, Section of Geriatrics, Chicago, IL, October 2003
  50. “Implementation of Intensity Modulated Radiation Therapy for patients with carcinoma of the cervix”. Panel 6. 45th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Salt Lake City, UT, October 20, 2003.
  51. “IMRT in Gynecologic Malignancies” Fourth Annual Community Hospital, IMRT Symposium and Workshop (Focus on Practical IMRT), Eatontown, NJ, November 2003.
  52. “Target Delineation in Gynecologic IMRT” Second International Target Delineation Symposium for IMRT/3DCRT Treatment Planning (MD Anderson Cancer Center), Boca Raton, FL, February 2004
  53. “IMRT in Gynecologic/Gastrointestinal Tumors” Fourteenth Annual Meeting, American College of Radiation Oncology (ACRO), Orlando, FL, February 2004
  54. “IMRT: The Clinician’s Perspective” American Society for Therapeutic Radiology and Oncology (ASTRO) IMRT Practicum, San Diego, CA, February 2004
  55. “IMRT in Clinical Practice” Northwest Indiana Education Foundation and St. Anthony’s Hospital. Michigan City, IN, April 2004
  56. “IMRT in Gynecologic Malignancies” Association of Chicago Gynecologic Oncologists. Chicago IL, May 2004
  57. “IMRT for the Hematologist” Section of Hematology/Oncology, University of Illinois at Chicago IL, May 2004
  58. “Radiation Oncology for the Dentist” Postgraduate course in Prosthodontics and Medical Art. Maxillofacial Prosthetics Clinic. University of Illinois at Chicago. July 2004.
  59. “Gynecologic IMRT: Status and Future Directions” Department of Radiation Oncology, Rush University Hospital, Chicago IL, August 2004
  60. “IMRT in Gynecologic Malignancies” US Oncology 2004 Radiation Oncology Meeting, Dallas TX, September 2004
  61. “IMRT: The Physician’s Perspective” Advanced Radiotherapy Consultants (ARC) IMRT Practicum, South Bend IN, September 2004
  62. “Role of Radiation Therapy in Endometrial Cancer” Advances in Ovarian and Endometrial Cancers Symposium, Case Western Reserve University, Cleveland OH, September 2004.
  63. “Radiation in Endometrial Cancer: How much is too much? How little is too little?” Gynecologic Oncology Oral Session (Invited Commentary). American Society for Therapeutic Radiology and Oncology (ASTRO), Atlanta, GA, October 2004.
  64. “Radiation Oncology in Head and Neck Cancer: Past, Present and Future” Department of Otolaryngology, University of Illinois at Chicago, Grand Rounds, November 2004
  65. “IMRT: The Physician’s Perspective” Advanced Radiation Oncology (ARC) IMRT Seminar, South Bend, IN, November, 2004
  66. “IMRT: A Revolution in the Treatment of Cancer” Grand Rounds, St. Mary’s Hospital, Hobart, IN, November, 2004
  67. “IMRT: Fact or Fiction (Debate). Controversies in the Management of Gynecologic Malignancies 5. Grand Hyatt New York, New York, NY, December 2004
  68. "IMRT: The Global View”. Third International Target Delineation Symposium for 3DCRT/IMRT Treatment Planning. Ritz-Carlton Hotel, Avon, CO, February 2005
  69. “Gynecologic IMRT: Practicum” Third International Target Delineation Symposium for 3DCRT/IMRT Treatment Planning. Ritz-Carlton Hotel, Avon, CO, February 2005
  70. “IMRT in Gynecologic Malignancies” American Society for Therapeutic Radiology and Oncology (ASTRO) IMRT Practicum. Dallas, TX, February 2005
  71. “IMRT in Gynecologic Malignancies” American College of Radiation Oncology (ACRO) Meeting. Las Vegas, NV, February 2005
  72. “IMRT: A Revolution in the Treatment of Cancer”. Section of Hematology-Oncology, University of California San Diego, San Diego, CA, April 2005
  73. “IMRT: The Physician’s Perspective” Advanced Radiation Oncology (ARC) IMRT Seminar, South Bend, IN, May, 2005
  74. “IMRT: Current Status and Future Directions”. Resident End of the Year Dinner. Washington University, Department of Radiation Oncology, St. Louis, MO, June 2005
  75. “IMRT in Gynecologic Malignancies” University of North Carolina, Radiation Oncology Grand Rounds, Chapel Hill, NC, June 2005
  76. “Role of Ethyol in the IMRT Era” MedImmune National Sales Conference, Lake Tahoe, CA, July 2005
  77. “Meta-Analysis of Randomized Clinical Trials of Ethyol in Locally Advanced Non-Small Cell Lung Cancer” MedImmune National Sales Conference, Lake Tahoe, CA, July 2005
  78. “Clinical Issues in IMRT/IGRT” IG-IMRT at Sea Practicum, University of Florida, Alaskan Cruise, July 2005
  79. “Site Specific Selection Criteria” IG-IMRT at Sea Practicum, University of Florida, Alaskan Cruise, July 2005
  80. “Dose Prescription, CTV and ORV Definitions” IG-IMRT at Sea Practicum, University of Florida, Alaskan Cruise, July 2005
  81. “Site Specific CTV-PTV Expansions” IG-IMRT at Sea Practicum, University of Florida, Alaskan Cruise, July 2005
  82. “Dose Constraints for PTV and Normal Tissues” IG-IMRT at Sea Practicum, University of Florida, Alaskan Cruise, July 2005
  83. “IMRT Plan Evaluation” IG-IMRT at Sea Practicum, University of Florida, Alaskan Cruise, July 2005
  84. “Case Presentation: Gynecologic IMRT” IG-IMRT at Sea Practicum, University of Florida, Alaskan Cruise, July 2005
  85. “Radiosurgery: Past, Present and Future” University of California, San Diego, Department of Neurosurgery Grand Rounds, San Diego, CA, August 2005
  86. “Intensity Modulated Radiation Therapy in Gynecologic Malignancies: Present Status, Future Directions” Twelfth Annual Meeting of the Japanese Society for 3DCRT, Osaka, Japan, August 2005
  87. “Intensity Modulated Radiation Therapy in Gynecologic Malignancies” 20th Annual Meeting of the Mid-Atlantic Gynecologic Oncology Society (MGOS), Wrightsville Beach, North Carolina, September 2005
  88. “Gynecologic IMRT: A Practicum” New Hanover Radiation Oncology Center, Wilmington, North Carolina, September 2005
  89. “IMRT and IGRT: Revolutions in the Treatment of Cancer” UC San Diego Cancer Center CME Open House Event, La Jolla, CA October 2005
  90. “IMRT and IGRT in Gynecologic Malignancies” Varian Users Meeting, Denver CO, October 2005
  91. “Difficult Cases in GYN Management” (Education Session 206) 47th Annual Meeting American Society for Therapeutic Radiology and Oncology, Denver CO, October 2005
  92. “Role of Radiation Therapy in Uterine Cancer” (ASTRO Refresher Course). 47th Annual Meeting American Society for Therapeutic Radiology and Oncology, Denver CO, October 2005
  93. “Radiation Oncology: Rehabilitation Perspectives” University of Illinois at Chicago Physical Therapy School, Chicago IL, December 2005
  94. “Radiation Oncology and Prostate Cancer: Current Approaches and Future Directions” University of Illinois at Chicago, Department of Urology Grand Rounds, Chicago IL, December 2005
  95. “Advancements in Radiation Therapy Technologies” La Grange Memorial Hospital, Grand Rounds, La Grange IL, January 2006
  96. “Intensity Modulated Radiation Therapy: Gynecologic and Gastrointestinal Tumors” 2006 ASTRO Practicum: Implementing IMRT in Clinical Practice, Dallas TX, February 2006.
  97. “IMRT Utilization” Fourth International Target Delineation Symposium for 3DCRT/IMRT Treatment Planning. Ritz-Carlton Hotel, Half Moon Bay, CA, February 2006
  98. “Gynecologic IMRT” Fourth International Target Delineation Symposium for 3DCRT/IMRT Treatment Planning. Ritz-Carlton Hotel, Half Moon Bay, CA, February 2006
  99. “Gynecologic IMRT Practicum” Fourth International Target Delineation Symposium for 3DCRT/IMRT Treatment Planning. Ritz-Carlton Hotel, Half Moon Bay, CA, February 2006
  100. “IMRT in Gynecologic Malignancies: Current Status and Controversial Issues” American College of Radiation Oncology (ACRO) Meeting. Orlando FL, February 2006
  101. “IMRT in Prostate Cancer: Current Status and Future Directions” Chicago Urological Society, Chicago IL, March 2006
  102. “Targeted Therapy in Gynecologic Malignancies” New York Roentgen Society, New York, NY April 2006
  103. “Gynecologic IMRT: An Update” Mt. Sinai Radiation Oncology Department, Visiting Professor, New York, NY April 2006
  104. “Gynecologic IMRT: State of the Art” St. Lukes Hospital, “State of the Art Treatments in Gynecologic Oncology”, Milwaukee WI, May 2006
  105. “Overview of Gynecologic IMRT: Current Status, Future Directions” American Radium Society, Kihei, Maui, May 2006
  106. “IGRT: Clinician Perspective” , Varian Medical Systems IGRT Seminar, Vegas NV, May 2006
  107. “IMRT em Pelve (Pelvic IMRT)”, 6th Curso de Radioterapia de Ultima Greracao: Avancos Tecnologicos e Controle de Qualidade, Hospital Sirio Libanes, Sao Paulo, Brazil, October 2006
  108. “Can IMRT Replace Brachytherapy in the Treatment of Gynecologic Tumors?”, 6th Curso de Radioterapia de Ultima Greracao: Avancos Tecnologicos e Controle de Qualidade, Hospital Sirio Libanes, Sao Paulo, Brazil, October 2006
  109. “IMRT: Past, Present and Future”, 6th Curso de Radioterapia de Ultima Greracao: Avancos Tecnologicos e Controle de Qualidade, Hospital Sirio Libanes, Sao Paulo, Brazil, October 2006
  110. “Role of Hypofractionation in Gynecologic Tumors”, Fox Chase Cancer Center Hypofractionation Symposia (Hypofractionation 2006: A Short Cut to the Future), Philadelphia, PA November 2006
  111. “IGRT Perspectives”, Varian User’s Meeting, Panel Presentation, Philadelphia, PA, November 2006
  112. “Role of Radiation Therapy in Uterine Cancer”, Refresher Course, 48th Annual Meeting American Society for Therapeutic Radiology and Oncology, Philadelphia, PA, November 2006
  113. “Gynecologic IMRT”, Visiting Faculty Scholar, Oregon Health and Science University (OHSU), Portland, OR, December 2006
  114. "IMRT in Endometrial Cancer”, Joint National Cancer/British National Cancer Research Institute Gynecologic Cancer Intergroup Endometrial Cancer State of the Science Meeting, Manchester, England, December, 2006
  115. “IMRT in Gynecologic Malignancies: Current Status, Future Directions” Seventh Annual Ana Speranza-Miller M.D. Symposium, Lutheran General Hospital. Chicago, IL, December, 2006
  116. “IMRT: The Global Overview”, 5th International Target Delineation Symposium for IMRT/3DCRT Treatment Planning, San Antonio, TX, January 2007
  117. “Gynecologic IMRT”, 5th International Target Delineation Symposium for IMRT/3DCRT Treatment Planning, San Antonio, TX, January 2007
  118. “IMRT in Gynecologic and Gastrointestinal Tumors”, 2007 American Society for Therapeutic Radiology and Oncology (ASTRO) Conference, San Francisco, CA, February 2007
  119. “Image-Guided Radiation Therapy (IGRT): Practicum Workshop”, 17th Annual Meeting of the American College of Radiation Oncology (ACRO), San Diego, CA, March 2007
  120. “Gynecologic Cancers: IMRT and IGRT”, 15th Semi-Annual Meeting of the Japan 3D Conformal External Beam Radiotherapy Group (J-CERG), Tokyo, Japan, March 2007
  121. “Varian IGRT Technologies”, Annual Region 1 Meeting of the American Association of Medical Dosimetrists (AAMD), Stevenson, WA, March 2007
  122. “Gynecologic IMRT”, Annual Region 1 Meeting of the American Association of Medical Dosimetrists (AAMD), Stevenson, WA, March 2007
  123. “Gynecologic IMRT and IGRT”, Visiting Professor Lecture, Case Western Reserve University, Cleveland, OH, April 2007
  124. “Advances in Gynecologic IMRT and IGRT”, New York Roentgen Society, New York, NY, April 2007
  125. “Integration of Brachytherapy and IMRT in Gynecologic Malignancies”, American Brachytherapy Society, Chicago, IL, April 2007
  126. “Advances in Radiation Oncology: New Technologies”, Cancer Survivorship X, Cancer Survivorship: San Diego!, San Diego, CA, June 2007
  127. “Roadblocks to Greater Public Acceptance of Radiation Therapy as a Treatment Option”, RT2020 Varian Focus Group Meeting, San Francisco, CA, June 2007
  128. “Integration of Brachytherapy and IMRT in the Treatment of Cervical Cancer”, International Conference on the Optimal Use of Advanced Radiotherapy in Multimodality Oncology, Rome Italy, June 2007
  129. “Current and Future Status of IMRT and IGRT in the United States”, Japanese Radiation Oncologists and Medical Physicists, Greater Tokyo Region, Tokyo, Japan, July 2007
  130. “Career Options in Oncology”, Preuss School Visit, Moores Cancer Center, San Diego, CA, July 2007
  131. “Gynecologic Cancers: IMRT and IGRT”, Peer Group Teleconference, Peer Group Inc., July 2007
  132. “Role of Stereotactic Radiotherapy/Radiosurgery in Hepatocellular Carcinoma”, UCSD Liver Transplantation Conference, San Diego, CA, August, 2007
  133. “Gynecologic IMRT and IGRT: Current Status, Future Directions”, Mayo Clinic Oncology Society, Mayo Clinic, Rochester MN, October 2007
  134. “IMRT and IGRT: the state-of-the-art”, Visiting Professorship, Mayo Clinic, Department of Radiation Oncology, Rochester MN, October 2007
  135. “Radiation Therapy in Prostate Cancer: Current Status and Future Directions”, Informed Prostate Cancer Support Group (IPCSG), La Jolla, CA, October 2007
  136. “Radiation Oncology: Past, Present and Future” UCSD Department of Medicine Grand Rounds, La Jolla CA, December 2007
  137. “IMRT and IGRT in Gynecologic Malignancies” Visiting Professorship, University of California Irvine, Irvine CA, January 2008
  138. “IMRT and IGRT: The Non-Varian Perspective” Varian National Sales Meeting, La Jolla CA January 2008
  139. “IMRT, IGRT and Adaptive Radiation Therapy” Varian Dallas IGRT Roadshow, Dallas TX, January 2008
  140. “Gynecologic IMRT: Current Status, Future Directions” American Society for Therapeutic Radiology and Oncology (ASTRO) IMRT Practicum, Orlando FL, February 2008
  141. “Image Guided Radiation Therapy in Prostate Cancer” UCSD Post-Graduate Course in Urology, Challenging Cases in Urologic Oncology, San Diego CA. February 2008
  142. “IMRT in Gynecologic Cancers”, Discussant, Society for Gynecologic Oncology (SGO), 39th Annual Meeting, Scientific Innovations Pathway to Progress in Women’s Cancer, Tampa FL, March 2008
  143. “Role of RT in Colorectal Cancer” UCSD Cancer Center Focus on Families: Prevention, Screening and Treatment of Colorectal Cancer, Moores Cancer Center, La Jolla CA, March 2008
  144. “IGRT in Brain, Head and Neck, Chest and Pelvic Malignancies”, American Society for Therapeutic Radiology and Oncology (ASTRO) IGRT Practicum, Newport Beach, CA March 2008
  145. “Role of Radiotherapy in Pancreatic Cancer” Moores Cancer Center Outreach Program in Pancreatic Cancer, Moores Cancer Center, La Jolla CA April 2008
  146. "IMRT and IGRT in Gynecologic Malignancies”, New York Roentgen Society Meeting, New York NY, April 2008
  147. “IMRT in Anal Carcinoma” Aptium Radiation Oncology Best Practices Conference, Miami Beach FL, April 2008
  148. “Image-Guided Adaptive IMRT in Cervical Cancer” Varian Research Partnership Symposium, Austin TX, April 2008
  149. “IGRT in Cervical Cancer” 90th Annual American Radium Society Meeting, Dana Point CA, April 2008
  150. “IMRT and IGRT in Gynecologic Malignancies: Current Status and Future Directions” Albert Einstein College of Medicine/Montefiore Medical Center, Invited Professorship, Bronx, NY, May 2008
  151. “IMRT in Cervical Cancer” Society for Gynecologic Oncology, Debate, Chicago, IL, June 2008
  152. “IMRT and IGRT in Gynecologic Malignancies: Current Status and Future Directions” University of Michigan, Invited Professorship, Ann Arbor MI, June 2008
  153. “Introduction to Radiation Oncology” Medical Oncology Friday Morning Fellow’s Conference, Moores Cancer Center, August 2008.
  154. "Radiation Oncology: Advancements in the Treatment of Metastatic Disease” Contemporary Forums’19th Annual Conference, Oncology: Clinical Issues and Trends, Las Vegas NV, September 2008.
  155. “Radiation Oncology” Kiwanis Club of Scripps Mira Mesa, San Diego, CA, September 2008.
  156. “IMRT and IGRT in Gynecologic Malignancies: Current Status and Future Directions” University of Colorado, Invited Professorship, Denver CO, October 2008
  157. “UCSD Radiation Oncology: Past, Present and Future” Annual Moores Cancer Center Scientific Retreat, San Diego CA, November 2008.
  158. “IMRT and IGRT in Gynecologic Malignancies: Current Status and Future Directions” Emory University, Invited Professorship, Atlanta GA, November 2008
  159. “Novel Radiation Technologies: Development and Clinical Implementation” UCSD Cancer Therapeutics Program, La Jolla CA, November 2008
  160. “Novel Treatment Approaches in Gynecologic Cancers: IMRT and IGRT”, Southern California Radiation Oncology Society (SCAROS)/ Los Angeles Radiologic Society (LARS), Los Angeles, CA, January 2009
  161. “IMRT and IGRT in Gynecologic Malignancies”, Kaiser Permanente, Invited Professorship, Los Angeles, CA, January 2009
  162. “IGRT in Gynecologic Malignancies: Current Status, Future Directions”, Plenary Talk, Annual Meeting of the American College of Radiation Oncology (ACRO), Las Vegas, NV, March 2009
  163. “New Approaches to Building Radiation Oncology Centers”, RAD Technology Sponsored Breakfast, Annual ACRO Meeting, Las Vegas, NV, March 2009
  164. “New Developments in Radiation Oncology”, Rancho Bernardo Kiwanis Club, Rancho Bernardo, CA, April 2009
  165. “Radiation Oncology: Past, Present and Future”, Encinitas Rotary Club, Encinitas, CA, April 2009
  166. “IMRT, IGRT and Beyond”, Varian Medical Systems Symposium, Santiago, Chile, May 2009
  167. “IMRT and IGRT in Gynecologic Tumors”, Jornada Paulista de Radiologica, Sao Paulo, Brazil, May 2009
  168. “Endometrial Cancer: Role of Radiotherapy in Early Stage Disease”, Jornada Paulista de Radiologica, Sao Paulo, Brazil, May 2009
  169. “IGRT in Gynecologic Malignancies”, American Society for Therapeutic Radiology and Oncology (ASTRO) IGRT/SBRT Symposium, Miami FL, May 2009
  170. “Prostate Cancer”, Spotlight on Cancer, Encinitas Library Cancer Series, Encinitas, CA, September 2009.
  171. “Radiation Oncology Advances in Prostate Cancer”, Rancho Sante Fe Community Center, San Diego, CA, September 2009
  172. “Advances in Radiation Oncology Technologies”, Annual Meeting of the California Cancer Registrars Association, San Diego, CA, October 2009
  173. “University of Chicago Radiation Oncology: 2000-2005”, Celebrating 25 Years of Excellence, University of Chicago Department of Radiation Oncology Reception, ASTRO 2009, Trump International Hotel and Tower, Chicago, IL, October 2009.
  174. “Advances in IMRT and IGRT in the treatment of gynecologic malignancies”, 2nd Annual Congress of the Asociacion Latinoamericana de Terapia Radiante Oncologica (ALATRO), Cancun , Mexico, November 2009.
  175. “Novel Non-Invasive Approaches in the Treatment of Cancer”, Moores Cancer Center Outreach Program, Moores Cancer Center, La Jolla, CA, November 2009
  176. “Advances in Image-Guided Radiation Therapy for Gynecologic Malignancies”, 8th Biennial Internal Symposium of the International Society for Strategic Studies in Radiology (IS3R) Meeting, La Jolla, CA, December 2009.
  177. "Cervical and Endometrial Cancer”, E-Contouring Practicum, American Society for Radiation Oncology, Chicago, IL, December, 2009.
  178. “Advances in Radiation Oncology”, UCSD Medical Center, Senior Leaders Meeting, San Diego, CA, February 2010
  179. “New Innovations in Radiation Oncology”, 1st Annual Spring Update on Cancer, Las Vegas, Nevada, April 2010.
  180. “Image-Guided and Intensity-Modulated Radiation Therapy in the Treatment of Gynecologic Malignancies”, Invited Professorship, Loyola University, Chicago, IL, May 2010.